15-acetoxyscirpen-3,4-diol: hydrolysis product of anguidine
ID Source | ID |
---|---|
PubMed CID | 429922 |
CHEBI ID | 175144 |
MeSH ID | M0067335 |
Synonym |
---|
CHEBI:175144 |
(10,11-dihydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl)methyl acetate |
anguidine,4-diol-bl5732) |
nsc-267030 |
desacetylanguidine |
trichothec-9-ene-3,15-triol, 12,13-epoxy-, 15-acetate, (3.alpha.,4.beta.)- |
trichothec-9-ene-3.alpha.,15-triol, 12,13-epoxy-, 15-acetate |
nsc267030 |
2623-22-5 |
15-acetoxyscirpen-3,4-diol |
15-acetylscirpenetriol |
deacetylanguidin |
15-o-acetylscirpenetriol |
monoacetoxyscirpenol |
nsc 267030 |
15-mono-o-acetylscirpenol |
15-acetoxyscirpenol |
4-deacetylanguidin |
IRXDUBNENLKYTC-UHFFFAOYSA-N |
scirp-9-ene-3.alpha.,4.beta.,15-triol, 12,13-epoxy-, 15-acetate |
(3.alpha.)-12,13-epoxytrichothec-9-ene-3,4,15-triol 15-acetate |
trichothec-9-ene-3,4,15-triol, 12,13-epoxy-, 15-acetate, (3.alpha.,4.beta.)- |
trichothec-9-ene-3.alpha.,4.beta.,15-triol, 12,13-epoxy-, 15-acetate |
15-mas |
15-acetoxy-3alpha,4beta-dihydroxy-12,13-epoxytrichothec-9-ene |
trichothec-9-ene-3alpha,4alpha,4beta)- |
anguidine, desacetyl(15-acetoxyscirpene-3,4-diol-bl5732) |
15-monoacetoxyscirpenol |
F85597 |
Class | Description |
---|---|
trichothecene | Any one of a large family of chemically related mycotoxins with a structure based on a sesquiterpene skeleton. The most important structural features causing the biological activities of trichothecenes are a 12,13-epoxy ring, the presence of hydroxy or acetyl groups at appropriate positions on the trichothecene nucleus and the structure and position of the side-chain. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |